Search hospitals
>
Ohio
>
Toledo
Mercy Health - Saint Anne Hospital
Claim this profile
Toledo, Ohio 43623
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
263 reported clinical trials
2 medical researchers
Summary
Mercy Health - Saint Anne Hospital is a medical facility located in Toledo, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Mercy Health - Saint Anne Hospital is involved with conducting 263 clinical trials across 368 conditions. There are 2 research doctors associated with this hospital, such as Timothy D. Moore and REX MOWAT, MD.
Area of expertise
Breast Cancer
Mercy Health - Saint Anne Hospital has run 58 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Mercy Health - Saint Anne Hospital has run 39 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Timothy D. Moore
The Mark H Zangmeister Center
6 years of reported clinical research
REX MOWAT, MD
Toledo Clinic Cancer Centers-Toledo
2 years of reported clinical research
Clinical Trials running at Mercy Health - Saint Anne Hospital
Lung Cancer
Bladder Cancer
Cancer
Breast Cancer
Melanoma
Ovarian Cancer
Cutaneous Melanoma
Bladder Carcinoma
Prostate Cancer
Multiple Myeloma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Health - Saint Anne Hospital?
Mercy Health - Saint Anne Hospital is a medical facility located in Toledo, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Mercy Health - Saint Anne Hospital is involved with conducting 263 clinical trials across 368 conditions. There are 2 research doctors associated with this hospital, such as Timothy D. Moore and REX MOWAT, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.